Feb 20, 2026, 17:59 ETVanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of...
WASHINGTON, Feb. 20, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™ (milsaperidone) tablets, a...